Stock listing
A2DQ8S Stock Price, News, Filings & Events — Ovid Therapeutics Inc.
Selected listing: A2DQ8S · LS · EUR · DE
This page tracks Ovid Therapeutics Inc.'s A2DQ8S:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2DQ8S:LS. A2DQ8S:LS is the stock-level entry point for investors researching Ovid Therapeutics Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A2DQ8S:LS
- Asset type
- Stock
- Market cap
- $546.8M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LS
- Currency
- EUR
Ovid Therapeutics Inc. A2DQ8S:LS stock context
This page tracks Ovid Therapeutics Inc.'s A2DQ8S:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2DQ8S:LS. A2DQ8S:LS is the stock-level entry point for investors researching Ovid Therapeutics Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Ovid Therapeutics Inc.
Ovid Therapeutics Reports Business Updates and Second Quarter 2026 Financial Results
August 13, 2026
Ovid Therapeutics Strengthens Executive Leadership Team to Support Continued Pipeline Progress and Next Phase of Development
July 8, 2026
Ovid Therapeutics Appoints Leading Physician-Scientist and Biotech Innovator Anna Greka, M.D., Ph.D., to Board of Directors
June 3, 2026
Ovid Therapeutics Reports Business Updates and First Quarter 2026 Financial Results
May 12, 2026
Ovid Therapeutics to Host Potassium-Chloride Co-transporter 2 (KCC2) Deep Dive R&D Event on Tuesday, April 14
April 8, 2026
Ovid Therapeutics Inc. earnings calls
Research Ovid Therapeutics Inc.
Ovid Therapeutics Inc. investor report
Review AI stock analysis and investor report context for A2DQ8S:LS.
Ovid Therapeutics Inc. company profile
View the public company page for Ovid Therapeutics Inc. on 6ix.
Ovid Therapeutics Inc. news
Read company news and market updates connected to Ovid Therapeutics Inc..
Ovid Therapeutics Inc. investor events
Find investor webinars, events, and replay context for Ovid Therapeutics Inc..
Alternate listings
OVID:NASDAQ
US · USD
Alternate listing for Ovid Therapeutics Inc.; the primary context on this page is A2DQ8S:LS.
1OT:GETTEX
DE · EUR
Alternate listing for Ovid Therapeutics Inc.; the primary context on this page is A2DQ8S:LS.
A2DQ8S:LSX
DE · EUR
Alternate listing for Ovid Therapeutics Inc.; the primary context on this page is A2DQ8S:LS.
OVID:BOATS
US · USD
Alternate listing for Ovid Therapeutics Inc.; the primary context on this page is A2DQ8S:LS.
1OT:TRADEGATE
DE · EUR
Alternate listing for Ovid Therapeutics Inc.; the primary context on this page is A2DQ8S:LS.
1OT:DUS
DE · EUR
Alternate listing for Ovid Therapeutics Inc.; the primary context on this page is A2DQ8S:LS.
1OT:FWB
DE · EUR
Alternate listing for Ovid Therapeutics Inc.; the primary context on this page is A2DQ8S:LS.
1OT:HAM
DE · EUR
Alternate listing for Ovid Therapeutics Inc.; the primary context on this page is A2DQ8S:LS.
1OT:MUN
DE · EUR
Alternate listing for Ovid Therapeutics Inc.; the primary context on this page is A2DQ8S:LS.
1OT:SWB
DE · EUR
Alternate listing for Ovid Therapeutics Inc.; the primary context on this page is A2DQ8S:LS.